Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment
S Sun, Q Yang, D Jiang, Y Zhang - Journal of Nanobiotechnology, 2024 - Springer
Cancer stem cells (CSCs) represent both a key driving force and therapeutic target of
tumoral carcinogenesis, tumor evolution, progression, and recurrence. CSC-guided tumor …
tumoral carcinogenesis, tumor evolution, progression, and recurrence. CSC-guided tumor …
CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
D Sanchis-Pascual, MI Del Olmo-García… - Cancers, 2024 - mdpi.com
Simple Summary Neuroendocrine neoplasms are a heterogeneous group of malignant
tumors that originate from the diffuse endocrine system. They generally have a slow course …
tumors that originate from the diffuse endocrine system. They generally have a slow course …
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology
N Dreher, S Hahner, CT Fuß, W Schlötelburg… - European Journal of …, 2024 - Springer
Background CXC motif chemokine receptor 4 (CXCR4) is overexpressed in various solid
cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to …
cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to …
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications
C Hunter, B Larimer - Nuclear Medicine and Biology, 2024 - Elsevier
Chemokine receptors are important components of cellular signaling and play a critical role
in directing leukocytes during inflammatory reactions. Their importance extends to numerous …
in directing leukocytes during inflammatory reactions. Their importance extends to numerous …
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies
Advancements in somatostatin receptor (SSTR) targeted imaging and treatment of well-
differentiated neuroendocrine tumors (NETs) have revolutionized the management of these …
differentiated neuroendocrine tumors (NETs) have revolutionized the management of these …
Neuroendocrine Tumors: Diagnostics
C Sakellis, HA Jacene - PET clinics, 2024 - pet.theclinics.com
Neuroendocrine neoplasms (NENs) are a heterogeneous class of tumors that arise from
secretory neuroendocrine cells that are found throughout the body. NENs are rare tumors …
secretory neuroendocrine cells that are found throughout the body. NENs are rare tumors …
Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas
K Michalski, W Schlötelburg, P Hartrampf… - Molecular Imaging and …, 2024 - Springer
Background Gastro-entero-pancreatic neuroendocrine carcinomas (GEP-NECs) are an
aggressive subgroup of neuroendocrine neoplasms (NENs). In patients affected with NEN …
aggressive subgroup of neuroendocrine neoplasms (NENs). In patients affected with NEN …
Diagnostic value of [68Ga] Ga-Pentixafor PET/CT in malignant melanoma: a pilot study
R Manafi-Farid, M Mahini… - Nuclear Medicine …, 2024 - journals.lww.com
Methods In this prospective study, patients with histology-proven melanoma were included
and underwent [18 F] fluoro-D-glucose ([18 F] FDG) and [68 Ga] Ga-Pentixafor …
and underwent [18 F] fluoro-D-glucose ([18 F] FDG) and [68 Ga] Ga-Pentixafor …
Neuroendocrine Neoplasms
R Modica, A Liccardi, R Minotta, G Cannavale… - 2024 - Springer
Neuroendocrine neoplasms (NEN) represent a rare and heterogeneous group of
malignancies, whose incidence is increasing trough the last decades, both because of better …
malignancies, whose incidence is increasing trough the last decades, both because of better …